Author: Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Crysler OV, Gupta N, Hall A, Johung KL, Klopp A, LaCasce AS, Lin C, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Palella F, Ratner L, Rizza S, Rudek MA, Sanchez J, Taylor J, Tomlinson B, Wang CJ, Yendamuri S, Dwyer M, Freedman-Cass D
Year: 2018
AGREE II score: Available
Developer organization: National Comprehensive Cancer Network
Type of cancer: Cervical, Gastrointestinal, Gynecological, Hematological, Lung, Not disease site specific
Patient population: Adult
Location: International
This is a clinical practice guideline for patients living with HIV (PLWH) who are diagnosed with cancer. The guideline focuses primarily on PLWH who develop non-small cell lung cancer (NSCLC), anal cancer, Hodgkin lymphoma, or cervical cancer. General advice is also provided regarding HIV management during cancer therapy, in addition to topics such as drug-drug interactions (DDI) between antiretroviral treatments and cancer therapies, initial workup, radiation therapy, surgical management, and supportive care.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 77.8%
Applicability: 31.2%
Stakeholder involvement: 72.2%
Editorial independence: 62.5%
Rigour: 65.6%
Clarity presentation: 75%
